PyroGenesis Canada Inc (PYRGF)

[Twotone]

More to the story:
Chief Medical Officer. Arun Upadhyay, PhD, previously Senior Vice President, Research & Development, will now serve as the Company's Chief Scientific Officer, overseeing the development and manufacturing of Ocugen's clinical and commercial product portfolio and evaluating new technologies.PyroGenesis Canada (PYR) provided an update further to its press release dated September 27th, which announced that the Company had signed a joint venture and license agreement with a leading residue processor to ultimately build and operate plants around the globe to transform dross residues (a by-product of the Company's DROSRITE process) into high value chemical and metallurgical products. The Company is proud to announce today that the JV Partner has completed primary testing of residues from an operational DROSRITE facility. The results confirm that the residues are of such high quality as to be able to be processed into highly marketable products.